SCHEMBL6989494

SCHEMBL6989494

CCC[C@](C/C(=C(/C)CC)[C@H](CC=Cc1ccccc1)C(=O)NO)(C(=O)NN)C(=O)[C@@H](C)N.Cc1ccc(S(=O)(=O)O)cc1

nearest known ligand 0.31

Known targets — ChEMBL curated mechanism

ABL1BMXBRAFBTKCHRNA4CHRNB2CSNK1EEGFRERBB2F10FLT1FLT3FLT4IGF1RINSRITKJAK3KDRKITOPRM1PARP1PARP2PDGFRBPIK3CDRAF1RETSLC18A2TECTXKdacAdacBdacCftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 1/20 0.31
CTSC P53634 1/20 0.31
GRIK1 P39086 1/20 0.30
GRIK2 Q13002 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7812038 0.91 CTSC (0.36) ADAM17CTSCGRIK1GRIK2
SCHEMBL6979893 0.83 GRIK1 (0.33) ADAM17CTSCGRIK1GRIK2
SCHEMBL6987634 0.82 ADAM17 (0.36) ADAM17CTSCGRIK1GRIK2
SCHEMBL6981566 0.81 ADAM17 (0.36) ADAM17CTSCGRIK1GRIK2
SCHEMBL6983429 0.79 ADAM17 (0.36) ADAM17GRIK1GRIK2
SCHEMBL6944604 0.77 ADAM17 (0.36) ADAM17CTSCGRIK1GRIK2
SCHEMBL6987789 0.77 CTSC (0.31) CTSC
SCHEMBL6986618 0.75 ADAM17 (0.37) ADAM17CTSC
SCHEMBL6987488 0.75 ADAM17 (0.31) ADAM17CTSCGRIK1GRIK2
SCHEMBL6986164 0.75 ADAM17 (0.31) ADAM17CTSCGRIK1GRIK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1089964-B1 HYDRAZINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2003-10-29 EP disclosed
US-6239151-B1 TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES, OSTEOARTHRITIS, RESPIRATORY DISEASES, TUMORS, CACHEXIA, CARDIOVASCULAR DISEASES, FEVER, HAEMORRHAGE AND SEPSIS, HYDRAZINE DERIVATIVES, HOFFMANN-LA ROCHE INC. 2001-05-29 US disclosed